Sign in
4

Changes in Ownership

Inhibikase Therapeutics, Inc. Filed Acc 0000899243-22-020094

President and CEO bought 5,000 shares at $0.98 ($4,880)

From the SEC's structured data for this filing

Trades in this filing

Werner Milton H. · President and CEO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2022-05-27 Purchase : show line 1 in the form +5,000 $0.98 $4,880 5,330,433 D
Open-market purchases · 5,000 sh · avg $0.98 · $4,880
Loading xslF345X03/doc4.xml…